Moreover, phenformin, in combination with anti-PD-1 administration, reduced the immunosuppressive expression of ARG1 by MDSCs, resulting in a synergistic effect in the induction of CD8+ T cells’ infiltration in TME and reduced tumor growth [232]. Here, ARG1 is linked to neoplasm.